Stephen Curry has spent pre-game warm-ups for years wearing what look like blood pressure cuffs strapped around his upper arms and thighs. They are not medical monitoring gear. They are pneumatic tourniquets set to partially restrict venous return while he does light bodyweight and band work courtside, and the goal is not circulation — it is forcing his muscles into an oxygen-starved state that mimics heavy lifting without any heavy lifting at all. Curry didn't invent this. Orthopaedic surgeons and rehab staff across the NFL, NBA and Premier League have been quietly building blood flow restriction, or BFR, into return-to-play protocols for the better part of a decade, and it has become one of the few genuinely useful tools for an athlete who cannot yet load a joint the way full training demands.
What is actually happening under the cuff
A BFR cuff — clinical systems use a pneumatic tourniquet, consumer versions use elastic wraps with a hand pump — sits at the top of the limb and is inflated to a fraction of the pressure needed to fully stop arterial blood flow. That threshold is called limb occlusion pressure (LOP), and protocols typically run at 40–80% of it, individually measured rather than guessed. Venous return out of the limb is restricted while arterial inflow keeps arriving, so blood pools in the working muscle. Within a couple of minutes of light exercise — usually 20–30% of one-rep max, a load most healthy adults could lift for 40-plus reps without a cuff — the muscle reaches metabolic failure in a fraction of the reps it would otherwise take.
The physiological cascade that follows is where the interest comes from. Cellular swelling, a spike in metabolites like lactate, and a surge in growth hormone and other anabolic signalling all occur at loads that would never normally trigger a hypertrophy response. A 2019 meta-analysis in the Journal of Sports Sciences pooling more than 50 BFR training studies found strength and hypertrophy gains broadly comparable to conventional high-load resistance training — at roughly a quarter of the mechanical stress on the joint. For an athlete six weeks post-ACL reconstruction, whose graft cannot yet tolerate a heavy squat, that trade-off is the entire point.
Where it earns its place in rehab, not just in gyms
This is the distinction that matters for competitive sport specifically. BFR shows up in two very different contexts, and conflating them undersells what it's actually for. In general strength training, it's a novelty — a way to get a hypertrophy stimulus with light dumbbells when heavy plates aren't available. In elite rehab, it solves a problem that has no other good solution: how do you keep atrophy from destroying a surgically repaired limb during the weeks it legally cannot bear real load? Saquon Barkley's public rehab documentation after his 2020 ACL tear showed BFR bands in near-daily use well before he was cleared for squatting. Physios call the alternative — weeks of near-total disuse while soft tissue heals — the single biggest driver of long-term deficits after knee reconstruction, because quadriceps strength that drops 30–40% in the first month rarely fully closes the gap even a year later. BFR doesn't replace the surgery or the graft-maturation timeline. It buys the muscle something to do while the joint catches up, which is a genuinely different job than the one it does in a normal gym.
The kit clubs and clinics actually use
Not all cuffs are equal, and the gap between them is a real clinical issue, not brand snobbery. The Delfi Personalized Tourniquet System is the closest thing to a research and clinical standard — it measures limb occlusion pressure automatically and holds it steady through a session, and it's the system behind most of the peer-reviewed BFR literature. A unit runs orthopaedic clinics and pro medical departments somewhere in the £3,500–£5,000 range, which prices it firmly out of home use and squarely into a physio's treatment room. Consumer alternatives — B Strong's kit and Smart Cuffs among the better-known names — sell for £350–£700 and use a hand pump rather than automated pressure regulation, which is why serious rehab programmes still lean on the clinical version for the first weeks post-surgery, when precision on pressure actually changes outcomes.
Kaatsu, the Japanese brand that pioneered the method under Dr Yoshiaki Sato in the late 1960s, still sells its own cuff systems and remains the most recognised name in Japan and among masters athletes, though it has largely lost ground in elite Western sport to Delfi's clinical dominance. Worth saying plainly: buying a consumer cuff and guessing at pressure is not the same intervention as a physio-supervised session on a calibrated system, and athletes who try to replicate hospital-grade rehab with a £400 box off the internet are taking on real risk for a fraction of the benefit.
The limits nobody markets
Deep vein thrombosis is the contraindication that gets the most attention, and rightly so — any intervention that restricts venous return in a limb needs proper screening for clotting history, varicose veins and cardiovascular risk factors before a cuff goes anywhere near a patient. Reputable clinics run that screening as standard; it's the consumer end of the market, where anyone can buy a set of bands and follow a YouTube protocol with no medical oversight, where the real exposure sits. There's also a ceiling on what BFR can do that gets glossed over in the enthusiasm: it builds muscle cross-sectional area and some strength, but it does very little for the tendon and ligament stiffness that actually determines whether a joint is ready for cutting, jumping or contact. An athlete can look strong on a BFR-driven recovery curve and still be nowhere close to ready for a return-to-sport test, because the graft and the surrounding connective tissue adapt on their own, much slower timeline regardless of how the muscle responds.
The honest recommendation for anyone actually rehabbing a serious injury is to treat BFR as a bridge tool under a physio's supervision, not a shortcut you run yourself — book time with a clinic that owns a Delfi system if the option exists locally, because the pressure precision is worth paying for in the first eight to twelve weeks. If you're weighing whether to add a set of cuffs to your own kit bag, ask your physio outright whether their clinic already runs a Delfi system before you spend money on a consumer version that does a rougher job of the same thing. For healthy competitive athletes looking to add BFR to an off-season strength block purely for the metabolic stimulus, the consumer cuffs are a reasonable, much cheaper way in, and there's no strong case for spending clinic money on a problem a properly loaded programme could solve anyway.
Why it's spreading through elite programmes now
Ten years ago BFR sat in a handful of university sports science labs and a small circle of Japanese practitioners. What changed is largely institutional: NFL, NBA and Premier League medical staffs now routinely rotate through sports science conferences where Delfi-sponsored research gets presented, and a generation of head physios trained during BFR's academic peak in the early 2020s have since moved into senior team roles. Where a decade ago a torn ACL meant six to eight weeks of near-total quad atrophy before meaningful strength work could resume, several NFL and Premier League medical departments now report starting supervised BFR within two to three weeks of surgery, once wound healing allows. That shift shows up on the pitch and court in a way that's hard to fully separate from other rehab advances happening in parallel — better graft techniques, more aggressive but still evidence-based loading timelines, sports psychology support for the mental side of a long absence. BFR isn't the whole story of why ACL return timelines have compressed since the mid-2010s. But ask any elite physio who's run both eras of a rehab protocol which single piece of kit changed the most about what's possible in week three, and the cuff on the thigh is usually the first thing they mention.